News Focus
News Focus
icon url

dr_lowenstein

05/21/21 3:04 PM

#356292 RE: no2koolaid #356290

200million wow what independent qualified analyst agrees with that projection ????!??
icon url

imanjen13

05/21/21 3:21 PM

#356293 RE: no2koolaid #356290

With this historically low volume, I wonder what happens if a new investor decides to buy lets day a million shares and tries to accumulate prudently without spiking the price. If and when this happens, long time suffers, looking for a reasonable exit, will have a chance to move on.

The opportunity may be available in the next 4-5 weeks as earnings day approaches. Good to see LCI numbers on CNS sales.
icon url

Just give me $1.50

05/21/21 6:20 PM

#356302 RE: no2koolaid #356290

WRONG.

Latest data is about $1.2 billion, down from $1.5 billion.

This much discussed potential CNS ANDA that he speaks of having a $1.5 B market (generic Concerta or something else) is based on September 2019 IQVIA numbers. With a CAGR at 8.5%, we can reasonably expect IQVIA to project this drug - whatever it might be - to be about $1.75 B market today.



icon url

Just give me $1.50

05/21/21 6:23 PM

#356303 RE: no2koolaid #356290

According to IQVIA Health, the Concerta brand and generic products had US sales of around USD 1.159 billion for the most recent 12 months ending in June 2020.

icon url

Je3232

05/24/21 7:40 AM

#356377 RE: no2koolaid #356290

not sure why there is any support dor this stock. i stay because it stand the thought of missing a run yet my better me says there's no way this POS moves
icon url

Je3232

05/24/21 8:59 AM

#356381 RE: no2koolaid #356290

LCI reported growth last quarter but it didn’t seem like the growth made its way to elites revenue